| Name | 5-Bromo-2-(trifluoromethyl)pyrimidine |
|---|---|
| Synonyms |
5-Bromo-2-(trifluoromethyl)pyrimidine
Pyrimidine, 5-bromo-2-(trifluoromethyl)- |
| Density | 1.8±0.1 g/cm3 |
|---|---|
| Boiling Point | 139.8±40.0 °C at 760 mmHg |
| Melting Point | 41-42ºC |
| Molecular Formula | C5H2BrF3N2 |
| Molecular Weight | 226.982 |
| Flash Point | 38.3±27.3 °C |
| Exact Mass | 225.935333 |
| PSA | 25.78000 |
| LogP | 1.49 |
| Appearance | Crystalline | White |
| Vapour Pressure | 7.9±0.2 mmHg at 25°C |
| Index of Refraction | 1.471 |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2933599090 |
|
~17%
799557-86-1 |
| Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2006/136442 A1, 2006 ; Location in patent: Page/Page column 92-93 ; WO 2006/136442 A1 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |